高级检索
    李艳, 闫屹, 张毛为, 嵇桂娟, 张文辉, 张志亮, 赵力, 陈碧. Ki-67表达与肺腺癌病理亚型及预后的关系[J]. 徐州医科大学学报, 2022, 42(4): 241-247. DOI: 10.3969/j.issn.2096-3882.2022.04.002
    引用本文: 李艳, 闫屹, 张毛为, 嵇桂娟, 张文辉, 张志亮, 赵力, 陈碧. Ki-67表达与肺腺癌病理亚型及预后的关系[J]. 徐州医科大学学报, 2022, 42(4): 241-247. DOI: 10.3969/j.issn.2096-3882.2022.04.002
    ex<x>pression of Ki-67 and its prognostic significance in lung adenocarcinoma according to histological subtype[J]. Journal of Xuzhou Medical University, 2022, 42(4): 241-247. DOI: 10.3969/j.issn.2096-3882.2022.04.002
    Citation: ex<x>pression of Ki-67 and its prognostic significance in lung adenocarcinoma according to histological subtype[J]. Journal of Xuzhou Medical University, 2022, 42(4): 241-247. DOI: 10.3969/j.issn.2096-3882.2022.04.002

    Ki-67表达与肺腺癌病理亚型及预后的关系

    ex<x>pression of Ki-67 and its prognostic significance in lung adenocarcinoma according to histological subtype

    • 摘要: 目的探讨Ki-67在肺腺癌病理亚型中的表达及其预后意义。方法回顾性分析2018年1月—2020年12月在徐州医科大学附属医院接受手术治疗的171例肺腺癌患者的癌组织标本及临床资料。应用免疫组织化学法检测肺腺癌组织内Ki-67的表达情况。评估Ki-67表达与肺腺癌病理亚型及其他临床病理特征、预后之间的关系。结果Ki-67在不同病理亚型中的表达不同,贴壁型Ki-67表达水平为15%(5%~20%),腺泡型15%(10%~30%),乳头型10%(7.5%~35%),微乳头型25%(10%~67.5%),实体型30%(25%~50%)(P<0.001)。1级、2级、3级肺腺癌中Ki-67表达水平分别为12.5%(5%~20%)、10%(5%~30%)、30%(20%~40%)(P<0.001)。含微乳头或实体成分的患者Ki-67表达更高(P<0.001),含贴壁成分的患者Ki-67表达更低(P=0.032)。此外,男性、吸烟、肿瘤直径大、淋巴结转移、胸膜脉管转移、TNM分期晚、实性结节与Ki-67表达升高有关。多因素Logistic 回归分析显示,病理亚型、肿瘤大小是Ki-67高表达的影响因素。生存分析显示Ki-67高表达者无病生存率显著降低(χ2=7.598,P=0.006)。结论Ki-67表达与肺腺癌3层分级系统、主要组织学亚型的分级系统显著相关,且其高表达提示预后不良。

       

      Abstract: ob<x>jective Ki-67 is a reliable marker to indicate the proliferative activity of tumor cells. In this study, we explore Ki-67 ex<x>pression and its prognostic significance in histological subtypes of lung adenocarcinoma (LUAD). Methods We retrospectively analyzed 171 LUAD patients who underwent surgery treatment between January 2018 and December 2020 in our department. The Ki-67 ex<x>pression was detected by immunehistocheistry. Associations between Ki-67 ex<x>pression and histological subtypes of LUAD, as well as other clinicopathological characteristics, prognosis of patients were evaluated. Results Ki-67 ex<x>pression differed across LUAD histological subtypes. The lepidic predominant adenocarcinoma had the lowest ex<x>pression level of Ki-67 15%(5%-20%), followed by acinar 15%(10%-30%), papillary 10%(7.5%-35%), micropapillary 25%(10%-67.5%),and solid predominant adenocarcinoma 30%(25%-50%)(P=0.0001). Tumors with solid or micropapillary components also had a higher Ki-67 ex<x>pression than those without solid or micropapillary components(P<0.0001). Lepidic components was associated with lower Ki-67 ex<x>pression (P<0.05). Besides, the ex<x>pression of Ki-67 was higher in males, smokers, patients with larger tumor size, lymph node me<x>tastasis, pleural lymphatic vessels invasion, higher TNM stage and solid nodule. Logistic regression analysis showed that patient’s gender, histological subtypes, diameter of tumor were influencing factors of high ex<x>pression of Ki-67. KM survival analysis showed that increased Ki-67 ex<x>pression was significantly associated with inferior disease-free survival(χ2=7.598,P =0.006). Conclusion The ex<x>pression of Ki-67 is related to histological subtypes of LUAD. High ex<x>pression of Ki-67 in LUAD is associated with poor prognosis.

       

    /

    返回文章
    返回